CT Findings in Surgically Treated Focal Pancreatic Disease- A Retrospective Study

Completed

• Conditions: Autoimmune Pancreatitis

• Registration Number: NCT06699667
• Lead Sponsor: Rigshospitalet, Denmark

Brief Summary

To retrospectively investigate CT imaging features of autoimmune and chronic pancreatitis (AIP and CP) mimicking pancreatic ductal adenocarcinoma in surgically resected patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-01-01
• Primary Completion: 2021-12-31
• Study Completion: 2021-12-31
• Status Verified: 2024-11
• Study First Submitted: 2024-11-14
• Study First Submitted QC: 2024-11-19
• Last Update Submitted: 2024-11-19
• Study First Posted: 2024-11-21
• Last Update Posted: 2024-11-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 41

Inclusion Criteria

• Definite diagnosis of autoimmune pancreatits or adenocarcinoma

Exclusion Criteria

• No surgery

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Imaging features of autoimmune pancreatitis	Time frame for each study object is the time between tumor board conference and surgery - typically 2-4 weeks	Patients with a final histopathological diagnosis of autoimmune pancreatitis is identified from pancreatic surgery database and compared with matched control groups. Imaging features available at the primary tumor board conference are evaluated blinded to the final diagnosis